the safety and efficacy of retreatment with venetoclax plus rituximab in r/r cll
Published 1 month ago • 88 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
1:36
improve study update: safety and efficacy of venetoclax retreatment in r/r cll
-
3:33
investigating the safety and efficacy of re-treating cll patients with venetoclax-based regimens
-
3:17
transcend-cll-004 study update: safety and efficacy of liso-cel in r/r cll
-
0:47
preliminary safety and efficacy of enitociclib in patients with nhl & cll
-
2:41
safety and efficacy of actaly-cel™ in r/r pediatric b-all
-
1:22
the safety and efficacy of vr-epoch for the management of richter's syndrome
-
4:38
venice i: venetoclax in r/r cll patients
-
25:23
quality control of blood components: the welsh experience
-
37:09
yale20 - hematology emergencies
-
10:39
risk management in the medical device industry in the eu
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
2:20
murano: venetoclax rituximab in birc3-mutated r/r cll
-
4:02
elm-2: promising safety and efficacy of odronextamab in r/r dlbcl
-
4:31
sequence of administration of ibrutinib with obinutuzumab in r/r cll patients
-
1:28
the future of cll treatment
-
5:20
advances in the use of bispecific antibodies for the treatment of cll
-
2:51
key btk inhibitor trials for the initial treatment of cll
-
2:25
monitoring infection risk in patients with cll & insights into the prevent-acall trial
-
2:52
updated analysis of phase iii trial of idelalisib combined with bendamustine and rituximab in cll
-
0:44
clinical efficacy and safety of ct-p10 in patients with dlbcl
-
1:55
phase 1b trial of idelalisib plus chemoimmunotherapy for relapsed/refractory cll
-
0:49
venice ii trial: health-related qol in patients with cll treated with venetoclax